Anti-PD-L1 Humanized Biotinylated Antibody | A2209

The research-grade biosimilar is a fully-humanized, Fc engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 (PD-L1). The antibody blocks the interaction of PD-L1 with PD-1 and induces anti-tumor immune reactivation.

A2209 | Anti-PD-L1 Humanized Biotinylated Antibody DataSheet

Antibody Target: PD-L1

Target Alternative Name: MPDL 3280A, MPDL-3280A, MPDL3280A, RG-7446, RG7446, PD-L1

Tag Line: Humanized monoclonal antibody to detect biotinylation of PD-L1 in human samples

Category: Primary antibody

Host: Recombinant

Isotype: IgG1, kappa

Species Reactivities: Human

Immunogen Sequence: Human programmed cell death 1 ligand 1 (PD-L1)

Accession #:

Gene ID: 29126

Appearance: Colorless liquid

Form: Liquid

Concentration:

Formulation: In PBS, pH 7.4

Purification: IgG purified from CHO culture supernatant by protein A chromatography

Application: ELISA

Positive Control:

Application And Usages: ELISA (1 ?g/ml)

Country of Animal Origin: USA

Country of Manufacture: USA

Usage: For Research Use Only! Not to be used in humans.

Handling: The antibody solution should be gently mixed before use.

Western Blot Verified: FALSE

Immunocytochemistry Verified: FALSE

Immunofluorescence Verified: FALSE

Immunoprecipitation Verified: FALSE

FACS Verified: FALSE

ELISA Verified: TRUE

ChIP Verified: FALSE

Dot Blot Verified: FALSE

Flow Cytometry Verified: FALSE